Dodderi S. Samiulla

496 total citations
16 papers, 404 citations indexed

About

Dodderi S. Samiulla is a scholar working on Oncology, Complementary and alternative medicine and Molecular Biology. According to data from OpenAlex, Dodderi S. Samiulla has authored 16 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Complementary and alternative medicine and 3 papers in Molecular Biology. Recurrent topics in Dodderi S. Samiulla's work include Cancer Immunotherapy and Biomarkers (6 papers), Peptidase Inhibition and Analysis (4 papers) and Immunotherapy and Immune Responses (3 papers). Dodderi S. Samiulla is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Peptidase Inhibition and Analysis (4 papers) and Immunotherapy and Immune Responses (3 papers). Dodderi S. Samiulla collaborates with scholars based in Malaysia, India and United States. Dodderi S. Samiulla's co-authors include D. Prashanth, Amit Agrawal, R. Padmaja, Murali Ramachandra, Raghuveer Ramachandra, Pottayil G. Sasikumar, Rashmi Nair, M.K. Asha, Jiju Mani and Hanudatta S. Atreya and has published in prestigious journals such as PLoS ONE, Cancer Research and International Journal of Pharmaceutics.

In The Last Decade

Dodderi S. Samiulla

16 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dodderi S. Samiulla Malaysia 9 186 109 89 74 46 16 404
Dae Won Park South Korea 10 68 0.4× 46 0.4× 47 0.5× 141 1.9× 25 0.5× 26 407
Hsia‐Fen Hsu Taiwan 13 83 0.4× 51 0.5× 41 0.5× 161 2.2× 44 1.0× 21 471
Elbert L. Myles United States 10 42 0.2× 68 0.6× 43 0.5× 150 2.0× 19 0.4× 19 441
Yiyi Ye China 11 86 0.5× 44 0.4× 27 0.3× 205 2.8× 20 0.4× 17 396
Dumrongsak Pekthong Thailand 13 84 0.5× 32 0.3× 102 1.1× 171 2.3× 30 0.7× 30 477
Sang‐Mi Woo South Korea 10 81 0.4× 35 0.3× 38 0.4× 208 2.8× 14 0.3× 12 379
Anjali Sharma India 8 84 0.5× 33 0.3× 43 0.5× 109 1.5× 13 0.3× 24 398
Ching-Lung Liao Taiwan 13 76 0.4× 46 0.4× 42 0.5× 284 3.8× 14 0.3× 14 506
Ariyaphong Wongnoppavich Thailand 12 36 0.2× 85 0.8× 32 0.4× 126 1.7× 17 0.4× 34 339
P.Y. Yu China 11 55 0.3× 47 0.4× 42 0.5× 209 2.8× 12 0.3× 18 415

Countries citing papers authored by Dodderi S. Samiulla

Since Specialization
Citations

This map shows the geographic impact of Dodderi S. Samiulla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dodderi S. Samiulla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dodderi S. Samiulla more than expected).

Fields of papers citing papers by Dodderi S. Samiulla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dodderi S. Samiulla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dodderi S. Samiulla. The network helps show where Dodderi S. Samiulla may publish in the future.

Co-authorship network of co-authors of Dodderi S. Samiulla

This figure shows the co-authorship network connecting the top 25 collaborators of Dodderi S. Samiulla. A scholar is included among the top collaborators of Dodderi S. Samiulla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dodderi S. Samiulla. Dodderi S. Samiulla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Palanisamy, Gopinath S., Venkateshappa Chandregowda, Brian R. Hearn, et al.. (2023). Abstract A044: The discovery of potent KAT6 inhibitors that demonstrate anti-tumor activity in preclinical models of ER+ breast cancer. Molecular Cancer Therapeutics. 22(12_Supplement). A044–A044. 1 indexed citations
2.
Sasikumar, Pottayil G., Raghuveer Ramachandra, Dodderi S. Samiulla, et al.. (2021). PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy. Communications Biology. 4(1). 699–699. 118 indexed citations
3.
Ojala, K., Anna Shevchenko, Timo Korjamo, et al.. (2021). How to stop disproportionation of a hydrochloride salt of a very weakly basic compound in a non-clinical suspension formulation. International Journal of Pharmaceutics. 606. 120875–120875. 4 indexed citations
4.
Thiyagarajan, Saravanan, Subhendu Mukherjee, Dodderi S. Samiulla, et al.. (2020). Potent anti-tumor activity of AUR102, a selective covalent inhibitor of CDK7. European Journal of Cancer. 138. S47–S47. 7 indexed citations
5.
Sasikumar, Pottayil G., Raghuveer Ramachandra, Dodderi S. Samiulla, et al.. (2019). A Rationally Designed Peptide Antagonist of the PD-1 Signaling Pathway as an Immunomodulatory Agent for Cancer Therapy. Molecular Cancer Therapeutics. 18(6). 1081–1091. 55 indexed citations
6.
Ahmad, Munirah, et al.. (2018). Ternary copper(II) complex: NCI60 screening, toxicity studies, and evaluation of efficacy in xenograft models of nasopharyngeal carcinoma. PLoS ONE. 13(1). e0191295–e0191295. 17 indexed citations
7.
Sasikumar, Pottayil G., Dodderi S. Samiulla, Raghuveer Ramachandra, et al.. (2016). Abstract 4861: Oral immune checkpoint antagonists targeting PD-L1/VISTA or PD-L1/Tim3 for cancer therapy. Cancer Research. 76(14_Supplement). 4861–4861. 11 indexed citations
8.
Sasikumar, Pottayil G., Raghuveer Ramachandra, Dodderi S. Samiulla, et al.. (2016). Pre-clinical efficacy in multiple syngeneic models with oral immune checkpoint antagonists targeting PD-L1 and TIM-3. European Journal of Cancer. 69. S98–S98. 4 indexed citations
9.
Sasikumar, Pottayil G., et al.. (2013). Abstract 1231: Equipotent antagonism, transient immune activation and excellent antitumor efficacy with a peptide inhibitor of PD-1 immune check point pathway.. Cancer Research. 73(8_Supplement). 1231–1231. 1 indexed citations
10.
Sasikumar, Pottayil G., Rajeev Shrimali, Krishnaprasad Subbarao, et al.. (2012). Abstract 2850: Demonstration of anti-tumor efficacy in multiple preclinical cancer models using a novel peptide inhibitor (Aurigene-012) of the PD1 signaling pathway. Cancer Research. 72(8_Supplement). 2850–2850. 12 indexed citations
11.
Agrawal, Amit, et al.. (2002). Estimation of Wedelolactone and Demethylwedelolactone in Eclipta alba Hassk. by Improved Chromatographic Analysis. Journal of Natural Remedies. 2(1). 99–101. 7 indexed citations
12.
Samiulla, Dodderi S., et al.. (2002). Trypsin inhibitory activity of Lawsonia inermis. Fitoterapia. 73(7-8). 690–691. 31 indexed citations
13.
Agrawal, Amit, et al.. (2001). An improved HPLC method for estimation of phyllanthin and hypophyllanthin in Phyllanthus amarus. Journal of Natural Remedies. 1(1). 55–59. 6 indexed citations
14.
Samiulla, Dodderi S., D. Prashanth, & Amit Agrawal. (2001). Mast cell stabilising activity of Bacopa monnieri. Fitoterapia. 72(3). 284–285. 45 indexed citations
15.
Prashanth, D., R. Padmaja, & Dodderi S. Samiulla. (2001). Effect of certain plant extracts on α-amylase activity. Fitoterapia. 72(2). 179–181. 39 indexed citations
16.
Prashanth, D., Amit Agrawal, Dodderi S. Samiulla, M.K. Asha, & R. Padmaja. (2001). α-Glucosidase inhibitory activity of Mangifera indica bark. Fitoterapia. 72(6). 686–688. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dae Won Park Breakdown of academic impact, for papers by Hsia‐Fen Hsu Breakdown of academic impact, for papers by Elbert L. Myles Breakdown of academic impact, for papers by Yiyi Ye Breakdown of academic impact, for papers by Dumrongsak Pekthong Breakdown of academic impact, for papers by Sang‐Mi Woo Breakdown of academic impact, for papers by Anjali Sharma Breakdown of academic impact, for papers by Ching-Lung Liao Breakdown of academic impact, for papers by Ariyaphong Wongnoppavich Breakdown of academic impact, for papers by P.Y. Yu
Rankless by CCL
2026